From GSD&M To Publicis

Leaving GSD&M for the second time in just over a decade was not a decision Klaudia Flanigin made lightly. But the offer to head a new GlaxoSmithKline account at Publicis in Mid-America as svp, group account director was one she says she did not want to pass up.

“It was very nice to be able to go back to a company I already knew,” said Flanigin, who began her career at the agency when it was known as Bloom.

In her new job (which she landed early this month), Flanigin will manage the direct-to-consumer account for GSK’s experimental vaccine Cervarix, which has been shown to prevent two forms of the virus that cause most cases of cervical cancer.